Related Experiment Video
Updated: Feb 8, 2026

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.5K
Hoarseness – causes and treatments
Summary
Hoarseness affects 1% of patients, with causes ranging from laryngitis to tumors. Persistent hoarseness requires medical evaluation and possible treatment like voice therapy or surgery.
Area of Science:
- Otolaryngology
- Speech and Hearing Sciences
Background:
- Hoarseness (dysphonia) is a common symptom prompting medical consultation in approximately 1% of patients.
- Causes are diverse, including laryngitis, functional dysphonia, vocal cord tumors, paresis, and aging voice, with internal diseases being rare.
- Acute laryngitis (42%) and functional dysphonia (30%) are the most frequent causes identified.
Purpose of the Study:
- To provide a comprehensive overview of the various causes of hoarseness.
- To outline diagnostic approaches for identifying the underlying etiology of dysphonia.
- To discuss available treatment options tailored to specific causes of hoarseness.
Main Methods:
- Literature review of causes, diagnosis, and treatment of hoarseness.
- Analysis of etiological distribution based on reported percentages.
- Emphasis on the diagnostic importance of laryngoscopy for persistent symptoms.
Main Results:
- Laryngitis (acute and chronic) and functional dysphonia constitute the majority of hoarseness causes.
- Benign and malignant tumors, vocal cord paresis, aging voice, and psychogenic factors represent less common etiologies.
- Internal diseases are identified as a rare cause of hoarseness.
Conclusions:
- Hoarseness has multifactorial origins, necessitating accurate diagnosis for effective management.
- Persistent hoarseness, defined as lasting over three weeks, warrants serious attention and laryngoscopic examination.
- Treatment strategies are cause-dependent, ranging from medication and voice therapy to surgical interventions.
Related Concept Videos
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
966
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
966
Anticholinesterase Agents: Poisoning and Treatment
1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K
Angle Closure Glaucoma: Treatment
1.3K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K

